Autoimmune Inner Ear Disease Clinical Trial
Official title:
An Open-label Study of the Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
The purpose of this study is to determine if gevokizumab therapy may be an alternate therapy in patients with steroid resistant Autoimmune Inner Ear Disease.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01526174 -
Intratympanic Injection for Autoimmune Inner Ear Disease
|
Phase 1/Phase 2 | |
Completed |
NCT01267994 -
A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT03587701 -
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
|
Phase 2 | |
Recruiting |
NCT04806282 -
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
|